Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
=================================================================================================================================================================

* Mizuki Nishino
* Maria Gargano
* Margaret Suda
* Nikhil H Ramaiya
* F Stephen Hodi